1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 18 APRIL 2016

Key Pharma News 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 22 pages

Industry Trend Analysis - GSK's Access Proposal Is Bold But Implementation Will Be Key
Industry Trend Analysis - Celgene Augments Long-Term Outlook
Industry Trend Analysis - AD Acquisition Heralds Allergan's New Strategy To Drive Growth
Industry Brief - Sun Pharma Acquires Prescription Brands From Novartis In Japan
Industry Trend Analysis - Highly Novel Therapies To Capitalise On China's Innovation Drive
Industry Trend Analysis - Gilead Steps Up Drive For Transformation
Industry Trend Analysis - Roche To Make High-Impact Entry Into PD-1/PD-L1 Arena
Industry Brief - Opdivo Becomes First PD-1 Inhibitor Approved For RCC In EU
Industry Trend Analysis - Sanofi's Dengvaxia Making Inroads In Asia
Industry Trend Analysis - Enhancing Portfolios Crucial To Counter Slowing CNS Development
Industry Trend Analysis - Lialda Weathers Generic Storms But Remains At Threat From PTO Ruling
Industry Trend Analysis - ADHD Revenues Will Underpin Shire's Rare Disease Pivot
Industry Brief - Amneal Launches Diclofenac Sodium Gel
Industry Trend Analysis - Genetic Medicine Will Drive Rare Disease Success
Industry Trend Analysis - FTC Intervention Threatens Generic Marketing Exclusivity Period Value
Industry Brief - Apotex Launches Filgrastim Biosimilar
Industry Trend Analysis - US Infliximab Approval Will Be A Boon For Pfizer And Celltrion
Industry Trend Analysis - EU Glatiramer Approval Positions Synthon To Compete With Sandoz
Industry Trend Analysis - AstraZeneca To Benefit From Clovis Setback
Industry Trend Analysis - AstraZeneca And Eli Lilly Accelerate Alzheimer's Drug Development

Table Of Contents

Key Pharma News 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.